Ueno A, Hamano T, Enomoto S, et al
Key mesolimbic reward areas, like the VTA and the NAc, are innervated by the GLP-1 producing neurons, potentially allowing hindbrain GLP-1 to modulate modulate reward behavior directly
The result: lower post-meal blood sugar, reduced appetite, and, for many patients, meaningful weight loss
Theres not much clinical research on medications to treat kratom withdrawal, but one case study reports successful treatment with buprenorphine, an opioid agonist medication commonly used to treat opioid use disorder
Choosing between a daily pill and a weekly injection depends on lifestyle and preference
Related dual-agonist compounds such as Survodutide provide additional comparative research tools for multi-receptor metabolic pathway investigation